Entasis Therapeutics Holdings financials at a glance
Year | Year | 2018 | 2019 | 2020 | 2021 | 2017 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$5.00M | $7.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
GM % | Gross Margin % |
|
100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | Earnings Per Share |
|
$0.00 | ||||||
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
13.1m | 13.29m | 35.48m | 47.64m | 0m | 47.85m | 0m |
OCF | Operating Cash Flow |
|
$-35.82M | $-44.74M | $-45.43M | $-42.97M | $-27.16M | $0.00M | $0.00M |
FCF | Free Cash Flow |
|
$-36.19M | $-44.85M | $-45.44M | $-43.04M | $-27.45M | $0.00M | $0.00M |
FCFS | Free Cash Flow Per Share |
|
$-10.58 | $-3.41 | $-1.89 | $-0.99 | $0.00 | $0.00 | $0.00 |